相关实验视频

Updated: May 18, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

在中识别适用于过敏免疫疗法的花生,适用于HLA-DRB1*03:01-限制患者的免疫疗法

Irini Doytchinova¹, Mariyana Atanasova¹, Stanislav Sotirov¹

¹Drug Design and Bioinformatics Lab, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

Pharmaceuticals (Basel, Switzerland)

|August 29, 2024

概括

这项研究确定了特定的花生过敏原,可以用于针对性免疫疗法,在个体具有共同的遗传易感性 (HLA-DRB1*03:01). 这种方法旨在提高花生过敏治疗的安全性和有效性.

科学领域:

免疫学免疫学免疫学
生物信息学是一种生物信息学.
过敏研究研究过敏

背景情况:

花生过敏是一种常见且严重的疾病.
特定的人类白细胞抗原 (HLA),如HLA-DRB1*03:01,与增加的花生过敏敏感性有关.
目前的治疗方法可能有局限性.

研究的目的:

开发一种用于识别过敏原的预测模型.
研究针对花生过敏的向免疫疗法策略.
为了提高HLA-DRB1*03:01.1患者的治疗安全性和疗效.

主要方法:

利用免疫信息学策略创建基于氨基酸频率的"标志模型".
来自28种已知花生过敏原的预测,它们与HLA-DRB1*03:01.01结合.
专注于HLA分子的酸结合核心.

主要成果:

成功预测了特定的花生过敏原衍生的,这些与易感性等位基结合HLA-DRB1*03:01.
这些已识别的是开发更安全的免疫疗法的潜在候选人.
这种方法可以准基本的表位,减少过敏性.

结论:

开发的标志模型可以识别用于免疫治疗的关键过敏原.
使用这些的向免疫疗法为花生过敏治疗提供了一个有希望的,更安全的替代方案.
这种策略可能会诱导免疫耐受性,在易受影响的个体中产生较少的不良影响.

关键词:

在 HLA-DRB1*03:01 中.免疫疗法免疫疗法标志方法标志方法对于花生过敏的过敏类结合的预测.

更多相关视频

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Basophil Activation Test for Allergy Diagnosis

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...